Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Tempus AI (NASDAQ: TEM ) reported second-quarter financial results Thursday after market close. Here are the key highlights. • Tempus AI stock is facing resistance. Why are TEM shares declining? Tempus AI Q2 Earnings Tempus AI revenue was $382.5 million in the second quarter, up 22% year-over-year. The revenue total be
Quest Diagnostics Incorporated (NYSE: DGX ) stock surged Thursday after the diagnostic testing company reported second-quarter results that topped Wall Street expectations and raised its full-year 2026 guidance. Earnings And Revenue Top Estimates Adjusted earnings rose to $3.12 per share, beating the analyst consensus
On Monday, Tempus AI, Inc. (NASDAQ: TEM ) agreed to acquire Personalis, Inc. (NASDAQ: PSNL ), aiming to advance cancer monitoring through enhanced minimal residual disease (MRD) capabilities. Tempus AI shares erased early losses and recovered after an initial selloff tied to the company’s acquisition of Personalis. Tem